Celldex Therapeutics (CLDX) Analyst & Key Data

Analyst Consensus

Buy16 analysts

Buy

Updated Sep 12, 2026

Total Analysts16

Buy

17

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$36.90

Median Target+38.21%

$51.00

Potential upside vs current price

DCF Value-99.40%

$0.22

Potential downside vs current price

Current Stock Price

$36.90

Median Target+38.21%

$51.00

Potential upside vs current price

DCF Value-99.40%

$0.22

Potential downside vs current price

Analyst Consensus

Buy16 analysts

Buy

Updated Sep 12, 2026

Total Analysts16

Buy

17

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$36.90

Median Target+38.21%

$51.00

Potential upside vs current price

DCF Value-99.40%

$0.22

Potential downside vs current price

Current Stock Price

$36.90

Median Target+38.21%

$51.00

Potential upside vs current price

DCF Value-99.40%

$0.22

Potential downside vs current price

Celldex Therapeutics, Inc.